ArticleJournal of translational medicine2026
Single-molecule localization microscopy imaging of extracellular vesicle DNA in recipient cells.
Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSmall extracellular vesicles (sEVs) are critical mediators of intercellular communication in both physiological and pathological contexts, including cancer, by transporting key biomolecules between cells. However, the biogenesis, packaging, and functional roles of DNA associated with sEVs (EV-DNA) remain poorly understood, largely due to the lack of efficient EV-DNA labeling dyes compatible with super-resolution imaging techniques.
resultsHere, we employed BODIPY, a green-emitting, buffer-independent blinking fluorophore, to label EV-DNA cargo and applied single-molecule localization microscopy (SMLM) for the first time under physiological conditions to achieve nanoscale imaging of EV-DNA in recipient cells. This approach overcomes conventional fluorophore limitations, enabling high-resolution dual-color imaging without quenching artifacts. We further developed a co-labeling strategy combining click chemistry (EV-DNA) and nanobody-based immunostaining (CD63-GFP⁺-sEVs), achieving precise multi-target labeling with a calculated linkage error of ~ 2 nm. Dual-color SMLM imaging revealed limited co-localization between EV-DNA and CD63-GFP⁺-sEVs, suggesting that EV-DNA may associate with distinct vesicle populations. Additionally, dual-color SMLM combined with cluster analysis indicated partial spatial proximity between EV-DNA and the cytoplasmic DNA sensor cyclic GMP-AMP synthase (cGAS), suggesting potential but limited functional interactions.
conclusionsThe SMLM-based imaging approach established in this study provides a powerful platform for investigating the packaging and subcellular fate of EV-DNA at nanometer resolution. Our results uncover new aspects of EV-DNA biology, including limited association with CD63⁺ vesicles and partial proximity to cGAS, suggesting alternative intracellular pathways. This versatile approach will enable detailed exploration of EV-DNA dynamics and its functional roles in health and disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.